We are monitoring the impact of COVID-19 & Recession alarm on North America Companion Diagnostics Market Get in touch with us for detailed analysis Know More
Share on

North America Companion Diagnostics Market Research Report – Segmented By Indication, Technology & Country (United States, Canada and Rest of North America) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 589
Pages: 145

North American Companion Diagnostics Market Size (2022 to 2027)

As per our report, the size of the North American Companion Diagnostics Market is estimated to be worth USD 4.07 billion by 2027 from USD 1.49 billion in 2022, growing at a CAGR of 22.25% from 2022 to 2027. The North American regional market is expected to dominate the global market during the forecast period. It is primarily driven by the growing number of cancer patients and increasing personalized healthcare knowledge. In addition, rising treatment costs and quality healthcare infrastructure are also good signs for the region's companion diagnostics market.

The rapid development of targeted therapies, increasing demand for personalized medicine, raising awareness in emerging economies, discovering new biomarkers in different contexts, and increasing unmet needs accelerate market growth.

Increased focus on targeted therapies and increased focus on the internal development of companion diagnostics by pharmaceutical companies are also driving the market growth. Also, more and more new areas of adaptation are significant opportunities in the market. Also, the longer approval processes and longer development times for the accompanying diagnostic procedures may hinder market growth in the coming years.

The poor reimbursement policies are the primary restraint for the growth of the North America Companion Diagnostics Market. In addition, long stages of development and approval are factors limiting the market growth.

This research report on the North American Companion Diagnostics Market has been segmented and sub-segmented into the following categories:

By Indications:

  • Oncology
    • Colorectal Cancer
    • Lung Cancer
    • Breast Cancer
    • Gastric Cancer
    • Melanoma
  • Inflammation and Autoimmune Diseases
  • Cardiovascular Diseases
  • Central Nervous System Disorders
  • Virology Diseases

By Technology:

  • Immunohistochemistry
  • Molecular Diagnostics
    • In-Situ Hybridization
    • Real-Time PCR
    • Gene Sequencing

By Country:

  • The United States
  • Canada
  • Rest of North America

Regional Analysis:

Geographically, the North American market had played a dominating role in the global companion diagnostics market in 2020. The high demand is for companion diagnostics in North America is due to the rising number of cancer patients in the region.

The United States companion diagnostics market is forecasted to lead the North American market, followed by Canada during the forecast period. Rising development in technology and increasing demand for personalized medicine in the United States are driving the market growth. The U.S. has a massive number of providers and pharmaceutical companies to develop companion diagnostic for oncology. According to the American cancer society, there are 2,28,820 lung cancer patients in the US, so the demand for companion diagnostic products increases tremendously. In 2020, U.S. Food and drug administration approval for targeted treatment for lung cancer with companion diagnostics will fuel the market in the next five years.

The Canadian companion diagnostics market is anticipated to grow at a healthy CAGR during the forecast timeline. The Canadian Agency of drugs and technology in health has started improving companion diagnostic systems for patient care. In addition, Roche diagnostics got approval for the EGFR mutation test, which will identify non-small cell lung cancer patients and drive the growth of the Canadian companion diagnostics market. Also, the changes in IVD regulation in medical devices of companion diagnostics will fuel the market growth.

KEY MARKET PLAYERS:

Companies playing a dominant role in the North America Companion Diagnostics Market profiled in this report are Abbott Molecular Inc., Roche Molecular Systems Inc., Leica Biosystems Nussloch GmbH, bioMérieux Inc., Dako Inc., Qiagen Ltd., ARUP Laboratories, Myriad Genetics Inc., Biogenex Laboratories Inc., Ventana Medical Systems Inc., and Thermo Fisher Scientific Inc.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 By Indications                            

                                5.1.1 Oncology 

                                                5.1.1.1 Colorectal Cancer

                                                5.1.1.2 Breast Cancer

                                                5.1.1.3 Lung Cancer

                                                5.1.1.4 Gastric Cancer

                                                5.1.1.5 Melanoma

                                5.1.2 Inflammation and Autoimmune Diseases  

                                5.1.3 Cardiovascular Diseases    

                                5.1.4 Central Nervous System Disorders               

                                5.1.5 Virology Diseases 

                5.2 By Technology                           

                                5.2.1 Immuno Histochemistry    

                                5.2.2 Molecular Diagnostics        

                                                5.2.2.1 In-Situ Hybridization

                                                5.2.2.2 Real Time PCR

                                                5.2.2.3 Gene Sequencing

6. Geographical Analysis                                              

                                6.1 Introduction               

                                6.2 United States            

                                6.3 Canada         

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Abbott Molecular Inc.                            

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues             

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Roche Molecular Systems Inc.                            

                8.3 Leica Biosystems Nussloch GmbH                     

                8.4 BioMérieux Inc.                        

                8.5 Dako Inc.                     

                8.6 Qiagen Ltd.                 

                8.7 ARUP Laboratories                  

                8.8 Myriad Genetics Inc.                              

                8.9 Biogenex Laboratories, Inc.                 

                8.10 Ventana Medical Systems Inc.                         

                8.11 Thermo Fisher Scientific Inc.                             

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Expert Opinions                                        

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  1. North America Companion Diagnostics Market By Region, From 2022 - 2027 (USD Billion)
  2. North America Companion Diagnostics Market By Indication, From 2022 - 2027 (USD Billion)
  3. North America Oncology Market By Region, From 2022 - 2027 (USD Billion)
  4. North America Inflammation and Autoimmune Diseases Market By Region, From 2022 - 2027 (USD Billion)
  5. North America Cardiovascular Diseases Market By Region, From 2022 - 2027 (USD Billion)
  6. North America Central Nervous System Disorders Market By Region, From 2022 - 2027 (USD Billion)
  7. North America Virology Diseases Market By Region, From 2022 - 2027 (USD Billion)
  8. North America Companion Diagnostics Market By Technology, From 2022 - 2027 (USD Billion)
  9. North America Immuno Histochemistry Market By Region, From 2022 - 2027 (USD Billion)
  10. North America Molecular Diagnostics Market By Region, From 2022 - 2027 (USD Billion)
  11. North America Oncology Diagnostics Market By Type, From 2022 - 2027 (USD Billion)
  12. North America Colorectal Cancer Diagnostics Market By Region, From 2022 - 2027 (USD Billion)
  13. North America Breast Cancer Diagnostics Market By Region, From 2022 - 2027 (USD Billion)
  14. North America Lung Cancer Diagnostics Market By Region, From 2022 - 2027 (USD Billion)
  15. North America Gastric Cancer Diagnostics Market By Region, From 2022 - 2027 (USD Billion)
  16. North America Melanoma Diagnostics Market By Region, From 2022 - 2027 (USD Billion)
  17. North America Molecular Diagnostics Market By Type, From 2022 - 2027 (USD Billion)
  18. North America In-Situ Hybridization Market By Region, From 2022 - 2027 (USD Billion)
  19. North America Real Time PCR Market By Region, From 2022 - 2027 (USD Billion)
  20. North America Gene Sequencing Market By Region, From 2022 - 2027 (USD Billion)
  21. United States Companion Diagnostics Market By Indication, From 2022 - 2027 (USD Billion)
  22. United States Companion Diagnostics Market By Technology, From 2022 - 2027 (USD Billion)
  23. United States Oncology Diagnostics Market By Type, From 2022 - 2027 (USD Billion)
  24. United States Molecular Diagnostics Market By Type, From 2022 - 2027 (USD Billion)
  25. Canada Companion Diagnostics Market By Indication, From 2022 - 2027 (USD Billion)
  26. Canada Companion Diagnostics Market By Technology, From 2022 - 2027 (USD Billion)
  27. Canada Oncology Diagnostics Market By Type, From 2022 - 2027 (USD Billion)
  28. Canada Molecular Diagnostics Market By Type, From 2022 - 2027 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample